Diabetes pill shows Real-World results in italian study
NCT ID NCT05230615
Summary
This study observed 458 Italian adults with type 2 diabetes who were prescribed the once-daily pill Rybelsus (oral semaglutide) by their doctor. Researchers tracked their blood sugar control and weight changes over 8-10 months to see how the medication works in everyday practice. Participants also completed surveys about their satisfaction with the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS MultiMedica
Sesto San Giovanni, Italy
-
Master Centre for Italy
Rome, 00144, Italy
Conditions
Explore the condition pages connected to this study.